These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16000251)

  • 1. Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women.
    Noh JJ; Maskarinec G; Pagano I; Cheung LW; Stanczyk FZ
    Breast; 2006 Feb; 15(1):20-8. PubMed ID: 16000251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous sex hormones, prolactin and mammographic density in postmenopausal Norwegian women.
    Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
    Int J Cancer; 2007 Dec; 121(11):2506-11. PubMed ID: 17657735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
    Tamimi RM; Byrne C; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma sex steroid hormones and breast cancer risk in Chinese women.
    Yu H; Shu XO; Shi R; Dai Q; Jin F; Gao YT; Li BD; Zheng W
    Int J Cancer; 2003 May; 105(1):92-7. PubMed ID: 12672036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous sex hormone levels and mammographic density among postmenopausal women.
    Tamimi RM; Hankinson SE; Colditz GA; Byrne C
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2641-7. PubMed ID: 16284390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic endogenous estrogen and progesterone vary by mammographic density phenotypes in premenopausal women.
    Iversen A; Frydenberg H; Furberg AS; Flote VG; Finstad SE; McTiernan A; Ursin G; Wilsgaard T; Ellison PT; Jasienska G; Thune I
    Eur J Cancer Prev; 2016 Jan; 25(1):9-18. PubMed ID: 25714648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II.
    Fortner RT; Eliassen AH; Spiegelman D; Willett WC; Barbieri RL; Hankinson SE
    Breast Cancer Res; 2013 Mar; 15(2):R19. PubMed ID: 23497468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of breast mitogens with mammographic densities.
    Boyd NF; Stone J; Martin LJ; Jong R; Fishell E; Yaffe M; Hammond G; Minkin S
    Br J Cancer; 2002 Oct; 87(8):876-82. PubMed ID: 12373602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-density lipoprotein-cholesterol, daily estradiol and progesterone, and mammographic density phenotypes in premenopausal women.
    Flote VG; Frydenberg H; Ursin G; Iversen A; Fagerland MW; Ellison PT; Wist EA; Egeland T; Wilsgaard T; McTiernan A; Furberg AS; Thune I
    Cancer Prev Res (Phila); 2015 Jun; 8(6):535-44. PubMed ID: 25804612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Hormones and Mammographic Density in Premenopausal Women.
    Bertrand KA; Eliassen AH; Hankinson SE; Rosner BA; Tamimi RM
    Horm Cancer; 2018 Apr; 9(2):117-127. PubMed ID: 29330698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of endogenous sex steroids and sex steroid binding proteins with mammographic density: results from the Postmenopausal Estrogen/Progestin Interventions Mammographic Density Study.
    Greendale GA; Palla SL; Ursin G; Laughlin GA; Crandall C; Pike MC; Reboussin BA
    Am J Epidemiol; 2005 Nov; 162(9):826-34. PubMed ID: 16177147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations among mammographic density, circulating sex hormones, and polymorphisms in sex hormone metabolism genes in postmenopausal women.
    Warren R; Skinner J; Sala E; Denton E; Dowsett M; Folkerd E; Healey CS; Dunning A; Doody D; Ponder B; Luben RN; Day NE; Easton D
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1502-8. PubMed ID: 16896040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women.
    Johansson H; Gandini S; Bonanni B; Mariette F; Guerrieri-Gonzaga A; Serrano D; Cassano E; Ramazzotto F; Baglietto L; Sandri MT; Decensi A
    Breast Cancer Res Treat; 2008 Mar; 108(1):57-67. PubMed ID: 17468953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increases in serum estrone sulfate level are associated with increased mammographic density during menopausal hormone therapy.
    Crandall CJ; Guan M; Laughlin GA; Ursin GA; Stanczyk FZ; Ingles SA; Barrett-Connor E; Greendale GA
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1674-81. PubMed ID: 18628419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No relationship between circulating levels of sex steroids and mammographic breast density: the Prospect-EPIC cohort.
    Verheus M; Peeters PH; van Noord PA; van der Schouw YT; Grobbee DE; van Gils CH
    Breast Cancer Res; 2007; 9(4):R53. PubMed ID: 17692133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
    Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of breast cancer risk factors with breast density in Hispanic women.
    Gapstur SM; López P; Colangelo LA; Wolfman J; Van Horn L; Hendrick RE
    Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1074-80. PubMed ID: 14578145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor and mammographic density in postmenopausal Norwegian women.
    Bremnes Y; Ursin G; Bjurstam N; Rinaldi S; Kaaks R; Gram IT
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):57-62. PubMed ID: 17220332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estradiol and progesterone receptor levels in human breast adenocarcinoma in relation to plasma estrogen and progesterone levels.
    Saez S; Martin PM; Chouvet CD
    Cancer Res; 1978 Oct; 38(10):3468-73. PubMed ID: 688231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.